Poland· PL-100421603
Methofill SD
A methotrexate product containing methotrexatum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Methotrexate is registered in 12 of 19 countries.
Countries holding a registration under ATC L01BA01 (methotrexate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Methotrexate · ATC L01BA01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Methotrexatum
- Manufacturer
- Accord Healthcare Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- L01BA01
- ATC class
- Methotrexate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991405595
- gtin05909991405601
- gtin05909991405618
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
949 interactions on record for methotrexate.
Graded by severity as the source publishes them — 107 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methotrexate · interactions on record
949 records
- 107 severe
- 466 moderate
- 17 minor
- 309 info
Most severe, free to view
- OmeprazoleA02BC01severe
- PantoprazoleA02BC02severe
- LansoprazoleA02BC03severe
- RabeprazoleA02BC04severe
50 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methotrexate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFOXIEMOeasyMed s.r.o., Praha 10
- SwedenInjexate 7,5 mg Injektionsvätska, lösning i förfylld injektorAccord Healthcare B.V.
- BelgiumBasitrin 7.5 mgBasic Pharma Manufacturing
- SwitzerlandMetoject 7.5 mg, InjektionslösungGebro Pharma AG
- ItalyAFSLAMET*S.F. GROUP S.R.L.
- NorwayMetexMedac Gesellschaft für klinische Spezialpräparate mbH, Hamburg
- IcelandMetojectpenmedac Gesellschaft für klinische Spezialpräparate GmbH
- SpainMETOJECT PEN 7.5 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAMedac Gesellschaft Für Klinische Spezialpräparate Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Ebetrexat, Methofill
- Belgium · Basitrin, Emthexate
- Bulgaria · Ebetrexat, Инжексат
- Cyprus · Injexate, Methotrexate Accord
- Czechia · Foxiemo, Injexate
- Germany · Lantarel, Lantarel Fs
- Denmark · Ebetrex, Emthexate
- Estonia · Ebetrex, Metex
- Spain · Bertanel, Imeth
- Finland · Ebetrex, Injexate
- France · Imenor, Imeth
- United Kingdom (Northern Ireland) · Ebetrex, Injexate
- Greece · Methobion, Methotrexate Pfizer
- Croatia · Ebetrexat, Methofill
- Hungary · Ebetrexat, Methofill
- Ireland · Methofill, Methotrexate Abcur
- Iceland · Jylamvo, Methotrexat Ebewe
- Italy · Afslamet, Immutrex
- Liechtenstein · Jylamvo, Nordimet
- Lithuania · Ebetrexat, Metex
- Luxembourg · Emthexate, Emthexate Teva Pharma
- Latvia · Ebetrex, Metex
- Malta · Methotrexate Aspire Pharma (Malta)
- Netherlands · Basitrin, Ebetrex
- Norway · Ebetrex, Jylamvo
- Portugal · Fauldexato, Ledertrexato
- Romania · Methotrexat Ebewe, Metorthrit
- Sweden · Ebetrex, Injexate
- Slovenia · Methofill, Metoject
- Slovakia · Foxiemo, Injexate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c24eb94b-70de-41d8-98fe-0def99a6f011 GET /v1/drugs/c24eb94b-70de-41d8-98fe-0def99a6f011?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań we wstrzykiwaczu",
"source": "urpl",
"strength": "7,5 mg",
"packaging": "05909991405595 ¦ Rp ¦ 132947\n1 wstrzykiwacz 0,15 ml\n05909991405601 ¦ Rp ¦ 132948\n4 wstrzykiwacze 0,15 ml\n05909991405618 ¦ Rp ¦ 132949\n8 wstrzykiwacze 0,15 ml",
"substance": "Methotrexatum 7.5 mg",
"common_name": "Methotrexatum",
"pl_product_id": "100421603",
"pozwolenie_nr": "215/19",
"auth_procedure": "IR",
"authorisation_validity": "2024-06-12"
}See everything about methotrexate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.